Delota Corp. operates in the Canadian healthcare sector, specializing in the retail of cannabis products, nicotine vapes, and alternative tobacco products. While the company has a reasonable gross margin of 32.6%, it struggles with profitability, evidenced by a negative net margin of -1.7% and a low EBITDA margin of 2.1%. Additionally, its liquidity ratios indicate potential financial strain, with a current ratio of 0.75 and a quick ratio of 0.36, raising concerns about its ability to meet short-term obligations. The high debt-to-equity ratio of 10.89 further complicates its financial health.
Loading financial metrics...
Debt of $4.8M is 4.7x the company's cash position of $1.0M.
Gross profit margin decreased from 38.4% to 31.8% compared to last year.
Company went from $1.0M profit to $-1.1M loss compared to last year.
Low debt-to-revenue ratio of 14.5% indicates conservative financial management.
Valuation, risk assessment, competitive positioning, and key insights — all in one report.
Other Pharmaceutical Retailers companies of a similar size
Based on 2027-Q1 (June 30, 2026)